Lisa J. States, MD
Professor of Clinical Radiology
Attending Radiologist, Children's Hospital of Philadelphia, Department of Radiology, Philadelphia, PA
Active Medical Staff, Pennsylvania Hospital, Department of Radiology, Philadelphia, PA
Director, Section of Oncologic Imaging, Children's Hospital of Philadelphia, Department of Radiology, Philadelphia, PA
Endowed Chair for Molecular Imaging, Children's Hospital of Philadelphia, Department of Radiology, Philadelphia, PA
Department: Radiology
Contact information
Children's Hospital of Philadelphia
Department of Radiology
3401 Civic Center Boulevard
Philadelphia, PA 19104
Department of Radiology
3401 Civic Center Boulevard
Philadelphia, PA 19104
Office: 267-425-7146
Fax: 267-425-7068
Fax: 267-425-7068
Email:
states@chop.edu
states@chop.edu
Education:
BA (Human Biology)
Stanford University, Stanford, CA, 1985.
MD (Medicine)
Weill Cornell Medical College, New York City, NY, 1989.
Permanent linkBA (Human Biology)
Stanford University, Stanford, CA, 1985.
MD (Medicine)
Weill Cornell Medical College, New York City, NY, 1989.
Description of Research Expertise
Interpretation of 18 FDOPA PET/CT used for the localization of a focal lesion of congenital hyperinsulinism.Sponsor and Principle Investigator. PROTOCOL: Expanded Access 18F-DOPA PET/CT.
Metaiodobenzylguanidine (131 I-MIBG) Therapy for Refractory Neuroblastoma and Paraganglioma/ Pheochromocytoma Expanded access protocol
Thyroid Gland Screening Surveillance in Childhood Cancer Survivors after Radiotherapy
PET/MRI Protocol Optimization. PI.
NEPENTHE Trial. Co-Investigator.
Description of Clinical Expertise
pediatric oncologypediatric nuclear medicine and Molecular Imaging
Pediatric PET/CT scan
Pediatric PET/MRI
Congenital hyperinsulinism imaging with 18FDOPA
musculoskeletal MRI
Description of Other Expertise
Lu-177 therapy protocolsSelected Publications
Ortiz J, Seif AE, States L, Mehta S, MacFarland SP, Zheng DJ: Gemcitabine and Oxaliplatin-Induced Veno-Occlusive Disease in a Pediatric Patient With Multiply Relapsed Germ Cell Tumor. Pediatr Blood Cancer 72(10), Oct 2025 Notes: e31945. doi: 10.1002/pbc.31945. Epub 2025 Jul 25.Wasserman JD, Schneider KW, Achatz MI, Nakano Y, Zelley K, Gallinger B, Bauer AJ, Becktell KD, Wassner AJ, Raiti L, Doria AS, States LJ, Stratakis CA, Brodeur GM, Diller LR, Kamihara J, Malkin D, Pajtler KW, Tamura C, Villani A, Widjaja E, Das A, Rednam SP.: Updated Recommendations for Pediatric Surveillance in Hereditary Endocrine Neoplasia Syndromes: Multiple Endocrine Neoplasias, Hyperparathyroidism-Jaw Tumor Syndrome, and Carney Complex. Clinical cancer research: an official journal of the American Association for Cancer Research 31(2): 3628-3637, September 2025 Notes: DOI: 10.1158/1078-0432.CCR-24-3860.
Gaze MN, Handkiewicz-Junak D, Hladun R, Laetsch TW, Sorge C, Sparks R, Wan S, Ceraulo A, Kluczewska-Galka A, Gamez-Cenzano C, States LJ, El Khouli R, Aimone P, Perraud K, Kollar G, Khanshan F, Blumenstein L, Brouri F, Giraudet AL: Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study. European journal of nuclear medicine and molecular imaging 52(11): 4001-4015, Septmeber 2025 Notes: DOI: 10.1007/s00259-025-07246-7.
Voss SD, Greer MC, Doria AS, Shkumat NA, Akbari E, Brodeur GM, States LJ.: Radiation Concepts and Considerations for Pediatric Cancer Predisposition Syndrome Surveillance: A Report from the 2023 AACR Childhood Cancer Predisposition Workshop. Clinical cancer research: an official journal of the American Association for Cancer Research 31(17): 3638-3643, September 2025 Notes: DOI: 10.1158/1078-0432.CCR-25-0597.
Treves ST, Fahey FH, Ferrer Valencia V, Burchell N, Burton C, Czachowski M, Grant FD, Lai H, Lim R, Nadel H, Pampaloni MH, Pandit-Taskar N, Parisi M, Seghers V, Shah S, Shulkin B, States L, Vali R, Yoo D, Zukotynski K.: 2024 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities. Journal of nuclear medicine technology 53(3): 193-179, Sep 2025 Notes: DOI: 10.2967/jnmt.125.270161.
Rednam SP, Kamihara J, Becktell KD, Brodeur GM, States LJ, Voss SD, Villani A, Zelley K, Malkin D, Nakano Y, Doria AS, Widjaja E, Pajtler KW, Schneider KW, Achatz MI, Diller LR, Gallinger B, Tamura C, Wasserman JD.: Update on Tumor Surveillance for Children with Hereditary Pheochromocytoma/Paraganglioma Syndromes. Clinical cancer research: an official journal of the American Association for Cancer Research 31(16): 3368-3376, August 2025 Notes: DOI: 10.1158/1078-0432.CCR-24-4354.
Prodigios J, States LJ, El Omeiri S, Lerebo W, Rapp JB: Detection of lung nodules in children comparing FDG PET/MR, T2WI, and ZTE with CT. European Society of Paediatric Radiology (ESPR) Annual Meeting and Postgraduate Course, Bucharest, Romania June 2025 Notes: Oral presentation.
Gaze MN, Handkiewicz-Junak D, Hladun R, Laetsch TW, Sorge C, Sparks R, Wan S, Ceraulo A, Kluczewska-Galka A, Gámez-Cenzano C, States LJ, El Khouli R, Aimone P, Perraud K, Kollar G, Khanshan F, Blumenstein L, Brouri F, Giraudet AL: Correction to: Safety and dosimetry of [177Lu]Lu-DOTA-TATE in adolescent patients with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumours, or pheochromocytomas and paragangliomas: Primary analysis of the Phase II NETTER-P study. European journal of nuclear medicine and molecular imaging May 2025 Notes: DOI: 10.1007/s00259-025-07344-6.
Maleki N, Albalooshi B, States L, Aboian M.: Advancing Pediatric Neuro-Oncology: The Power of PET/MRI. American Society of Neuroradiology (ASNR) Annual Meeting, Philadelphia, PA May 2025 Notes: #667; Poster presentation.
Burrill N, Teefey CP, Wright R, Huynh MH, Schindewolf E, Pilchman L, Crane H, Noyes AG, Roman A, Gulersen M, Moldenhauer JS: Phenotypic Expansion: Fetus With Cole-Carpenter Type 2 Presenting With Novel Neonatal Lethal Skeletal Dysplasia. American journal of medical genetics. Part A 197(5): e63988, May 2025.